Day: May 28, 2022

Press Release

ROSEN, A LEADING LAW FIRM, Encourages Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ARQQ, ARQQW, CENH, CENHU, CENHW

NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. (NASDAQ: ARQQ, ARQQW, CENH, CENHU, CENHW): (i) between September 7, 2021 and April 18, 2022, both dates inclusive (the “Class Period”); and/or (ii) all […]

Read More
Press Release

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages IronNet, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – IRNT

NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of IronNet, Inc. (NYSE: IRNT) between September 15, 2021 and December 15, 2021, inclusive (the “Class Period”), of the important June 21, 2022 lead plaintiff deadline. SO WHAT: If you purchased IronNet […]

Read More
Press Release

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages HUMBL, LLC Investors to Secure Counsel Before Important Deadline in Securities Class Action – HMBL

NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of HUMBL, LLC (OTC: HMBL) and/or the Company’s unregistered digital asset (sold as BLOCKS Exchange Traded Index (“ETXs”) on various cryptocurrency exchanges) […]

Read More
Press Release

ABBV SHAREHOLDER ALERT: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important June 6 Deadline in Securities Class Action – ABBV

NEW YORK, May 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AbbVie Inc. (NYSE: ABBV) between April 30, 2021 and August 31, 2021, inclusive (the “Class Period”), of the important June 6, 2022 lead plaintiff deadline. SO WHAT: If you purchased AbbVie […]

Read More